Source comparison
Best Peptides for MCL Injury: Comparison
BPC-157 VEGF upregulation, angiogenesis, fibroblast migration 200–500 mcg/day Daily (subcutaneous, near injury site) Acute inflammatory (days 1–10) Strongest early-phase evidence; short half-life requires daily dosing TB-500 Actin regulation, cell migration, f
This comparison does not assign a generated winner or score.
- BPC-157
- VEGF upregulation, angiogenesis, fibroblast migration
- 200–500 mcg/day
- Daily (subcutaneous, near injury site)
- Acute inflammatory (days 1–10)
- Strongest early-phase evidence; short half-life requires daily dosing
- TB-500
- Actin regulation, cell migration, fibrosis reduction
- 2–2.5 mg/dose
- Twice weekly
- Proliferative (days 7–28)
- Systemic effect; reduces scar tissue formation
- GHK-Cu
- Collagen/elastin synthesis, lysyl oxidase activation
- 1–3 mg/dose
- 2–3 times weekly
- Remodeling (days 21–60)
- Cross-links collagen for tensile strength; requires copper ion